It is specifically indicated for the treatment of obesity resulting from genetic disorders such as proopiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1 (PCSK1), and leptin receptor (LEPR) deficiency26, 27. Here, POMC is linked to obesity due to melanocortin 4 receptor deficiency.